Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
6.95
+0.05 (0.72%)
Nov 20, 2025, 11:31 AM EST - Market open
Biodesix Revenue
Biodesix had revenue of $21.77M in the quarter ending September 30, 2025, with 19.93% growth. This brings the company's revenue in the last twelve months to $80.17M, up 22.29% year-over-year. In the year 2024, Biodesix had annual revenue of $71.32M with 45.30% growth.
Revenue (ttm)
$80.17M
Revenue Growth
+22.29%
P/S Ratio
0.64
Revenue / Employee
$293,674
Employees
273
Market Cap
55.29M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 71.32M | 22.24M | 45.30% |
| Dec 31, 2023 | 49.09M | 10.88M | 28.46% |
| Dec 31, 2022 | 38.21M | -16.29M | -29.89% |
| Dec 31, 2021 | 54.51M | 8.95M | 19.64% |
| Dec 31, 2020 | 45.56M | 21.01M | 85.55% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
BDSX News
- 16 days ago - Biodesix, Inc. (BDSX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 16 days ago - Biodesix Announces Third Quarter 2025 Results and Highlights - GlobeNewsWire
- 21 days ago - Biodesix to Share its R&D Roadmap during its Corporate Day Presentation at AMP Annual Meeting - GlobeNewsWire
- 4 weeks ago - Biodesix Announces Expanded Bio-Rad Laboratories Partnership Agreement to Develop Droplet Digital™ PCR High Complexity Assays - GlobeNewsWire
- 4 weeks ago - Biodesix to Report Third Quarter 2025 Financial Results on November 3, 2025 - GlobeNewsWire
- 5 weeks ago - Biodesix Announces Presentations and Events at the CHEST 2025 Annual Meeting - GlobeNewsWire
- 6 weeks ago - Biodesix Unveils October Lung Health Events in Colorado with the Association of Pulmonary Advanced Practice Providers (APAPP), American Lung Association in Colorado, and GO2 for Lung Cancer Centers of Excellence Summit - GlobeNewsWire
- 2 months ago - Biodesix Announces One-for-Twenty Reverse Stock Split - GlobeNewsWire